nitroblue tetrazolium has been researched along with cyclosporine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y; Hasegawa, A; Mortola, E; Ohno, K; Tsujimoto, H; Watari, T | 1 |
| Bunge, MB; Hill, CE; Moon, LD; Wood, PM | 1 |
2 other study(ies) available for nitroblue tetrazolium and cyclosporine
| Article | Year |
|---|---|
The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus.
Topics: Animals; Apoptosis; Calcium; Cats; Cell Line; Cyclosporine; DNA Fragmentation; Electrophoresis; Enzyme-Linked Immunosorbent Assay; Feline Acquired Immunodeficiency Syndrome; Immunodeficiency Virus, Feline; Immunosuppressive Agents; Indicators and Reagents; Nitroblue Tetrazolium; RNA-Directed DNA Polymerase; Tacrolimus; Virus Replication | 1998 |
Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Cell Survival; Cyclosporine; Female; Humans; Immunosuppressive Agents; Necrosis; Nitroblue Tetrazolium; Placenta; Rats; Rats, Inbred F344; Receptor, Nerve Growth Factor; Schwann Cells; Spinal Cord Injuries | 2006 |